-- Brooks Rehabilitation Hospital adds a second site to the registrational program in stroke, and brings the total number of…
VANCOUVER, British Columbia, Jan. 11, 2024 (GLOBE NEWSWIRE) -- Algernon Pharmaceuticals Inc. (the “Company” or “Algernon”) (CSE: AGN) (FRANKFURT: AGW0) (OTCQB:…
TELUS Ventures invests in Clinia to accelerate growth leading CAD $10M Series A financing round Partnership to revolutionize healthcare experience…
Dividend amount (per share): NOK 0.75 Declared currency: NOK Last day including right: 22 January 2024 Ex-date: 23 January 2024…
Oslo, Norway, 11 January 2024 Norwegian pharmaceutical company Vistin Pharma ASA (“Vistin Pharma”) announced today that the Board has decided for…
— NDA accepted and granted Priority Review following its Breakthrough Therapy designation granted in January 2022 — — NDA is…
- ATTRibute-CM demonstrated a significant treatment effect of acoramidis on the primary endpoint (a hierarchical analysis inclusive of all-cause mortality…
BIOCARTIS GROUP NV (Euronext Brussels: BCART) PRESS RELEASE - REGULATED INFORMATION - 10 January 2024, 23:00 CET Disclosure of transparency…
BIOCARTIS GROUP NV (Euronext Brussels: BCART) PRESS RELEASE - REGULATED INFORMATION - 10 January 2024, 23:00 CET Disclosure of transparency…
SAN DIEGO, Jan. 10, 2024 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX) today announced that on January 10, 2024,…